Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.6 USD | -1.95% | -0.91% | +11.86% |
Feb. 28 | Kiniksa Pharmaceuticals' Q4 Earnings, Revenue Increase | MT |
Feb. 28 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q4 2023 Earnings Call, Feb 28, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.86% | 1.41B | |
+2.86% | 108B | |
+9.50% | 104B | |
+6.58% | 23.66B | |
-12.28% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.58% | 16.19B | |
+4.27% | 13.72B | |
+32.95% | 12.22B |
- Stock
- Equities
- Stock Kiniksa Pharmaceuticals, Ltd. - Nasdaq
- News Kiniksa Pharmaceuticals, Ltd.
- Kiniksa Pharmaceuticals' : Q2 Loss Narrows